Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.97 is 81% above its 5-year average of 4.96, around the middle of its 5-year range (1.53–21.02).
As of the fiscal period ended Tuesday, June 30, 2026. 17.42% above its 12-month average of 7.64.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.97.
QUICK RATIO (ACID-TEST)
8.97
QUICK RATIO (ACID-TEST) AVG TTM
7.64
QUICK RATIO (ACID-TEST) AVG 3Y
6.21
QUICK RATIO (ACID-TEST) AVG 5Y
4.96
QUICK RATIO (ACID-TEST) AVG 10Y
3.85
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+17.42%
CURRENT VS 3Y AVG
+44.53%
CURRENT VS 5Y AVG
+80.76%
CURRENT VS 10Y AVG
+132.89%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.25
median of 789 covered companies
CURRENT VS SECTOR MEDIAN
+175.99%
vs the sector median at left
Kiora Pharmaceuticals, Inc.
Market Cap
$11.46M
Quick Ratio (Acid-Test)
8.97
TTM Avg
7.64
3Y Avg
6.21
5Y Avg
4.96
Market Cap
$11.45M
Quick Ratio (Acid-Test)
1.08
TTM Avg
1.28
3Y Avg
1.24
5Y Avg
1.80
Market Cap
$11.61M
Quick Ratio (Acid-Test)
15.87
TTM Avg
27.51
3Y Avg
16.79
5Y Avg
13.69
Market Cap
$10.94M
Quick Ratio (Acid-Test)
1.37
TTM Avg
0.79
3Y Avg
1.08
5Y Avg
1.46
Market Cap
$11.11M
Quick Ratio (Acid-Test)
5.63
TTM Avg
4.29
3Y Avg
4.04
5Y Avg
3.65
Market Cap
$12.12M
Quick Ratio (Acid-Test)
1.08
TTM Avg
1.32
3Y Avg
1.15
5Y Avg
1.64
Market Cap
$10.96M
Quick Ratio (Acid-Test)
4.93
TTM Avg
13.09
3Y Avg
13.09
5Y Avg
13.09
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiora Pharmaceuticals, Inc. (KPRX) | $11.46M | 8.97 | 7.64 | 6.21 | 4.96 |
| Biofrontera Inc. (BFRI)vs › | $11.45M | 1.08 | 1.28 | 1.24 | 1.80 |
| Pluri Inc. (PLUR)vs › | $11.11M | 0.27 | 0.48 | 3.83 | 4.93 |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.61M | 15.87 | 27.51 | 16.79 | 13.69 |
| BioVie Inc. (BIVI)vs › | $11.12M | 3.59 | 6.34 | 4.40 | 4.46 |
| Cerenome, Inc. (CNSY)vs › | $10.94M | 1.37 | 0.79 | 1.08 | 1.46 |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.11M | 5.63 | 4.29 | 4.04 | 3.65 |
| IRIDEX Corporation (IRIX)vs › | $12.12M | 1.08 | 1.32 | 1.15 | 1.64 |
| Caring Brands, Inc. (CABR)vs › | $10.96M | 4.93 | 13.09 | 13.09 | 13.09 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | 3.69 | 5.96 | 7.84 | 10.45 |
Quick Ratio
8.97
Excludes inventory
Current Ratio
8.97
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.97 |
| 2026-03-31 | 6.68 |
| 2025-12-31 | 5.99 |
| 2025-09-30 | 8.79 |
| 2025-06-30 | 7.76 |
| 2025-03-31 | 5.14 |
| 2024-12-31 | 4.94 |
| 2024-09-30 | 8.97 |
| 2024-06-30 | 19.22 |
| 2024-03-31 | 21.02 |
| 2023-12-31 | 2.90 |
| 2023-09-30 | 3.32 |
| 2023-06-30 | 4.79 |
| 2023-03-31 | 2.61 |
| 2022-12-31 | 2.35 |
| 2022-09-30 | 2.21 |
| 2022-06-30 | 1.53 |
| 2022-03-31 | 2.60 |
| 2021-12-31 | 5.59 |
| 2021-09-30 | 6.06 |
| 2021-06-30 | 3.07 |
| 2021-03-31 | 4.90 |
| 2020-12-31 | 0.87 |
| 2020-09-30 | 3.76 |
| 2020-06-30 | 6.37 |
| 2020-03-31 | 8.05 |
| 2019-12-31 | 3.06 |
| 2019-09-30 | 1.43 |
| 2019-06-30 | 5.43 |
| 2019-03-31 | 6.48 |
| 2018-12-31 | 2.19 |
| 2018-09-30 | 2.54 |
| 2018-06-30 | 3.21 |
| 2018-03-31 | 1.19 |
| 2017-12-31 | 0.57 |
| 2017-09-30 | 0.81 |
| 2017-06-30 | 1.13 |
| 2017-03-31 | 0.62 |
| 2016-12-31 | 0.57 |
| 2016-09-30 | 1.02 |
| 2016-06-30 | 1.72 |
| 2016-03-31 | 1.47 |
| 2015-12-31 | 2.76 |
| 2015-09-30 | 7.12 |
| 2015-06-30 | 2.23 |
| 2015-03-31 | 6.03 |
| 2014-12-31 | 0.04 |
| 2014-09-30 | 0.07 |
| 2014-06-30 | 0.10 |
| 2014-03-31 | 0.18 |
| 2013-12-31 | 0.22 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
